iRhythm Technologies Inc. (IRTC) stock plummeted 5.93% during intraday trading on Friday, as the market reacted to a series of downward revisions in analyst price targets for the company.
The sell-off appears to be driven by negative analyst actions, with several major investment firms significantly lowering their price targets for iRhythm. JPMorgan cut its target to $175 from $215, Oppenheimer reduced its target to $185 from $225, and Evercore ISI lowered its target to $160 from $170.
These downward revisions by multiple analysts suggest growing concerns about the company's future prospects, prompting investors to adjust their positions during the trading session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.